EMD 273063
EMD 273063 Uses, Dosage, Side Effects, Food Interaction and all others data.
EMD 273063 is under investigation in clinical trial NCT01334515 (Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma).
| Trade Name | EMD 273063 |
| Generic | Lorukafusp alfa |
| Lorukafusp alfa Other Names | EMD 273063, HU14.18-IL2, Lorukafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here EMD 273063
